這是一項單臂研究，探討將於威爾斯親王醫院進行的人工智能輔助 Uro-Cam 導管評估的安全性、可行性及診斷表現。所有因血尿檢查轉介至泌尿科門診的患者，以及需要接受膀胱鏡隨訪的膀胱癌患者，均將接受研究資格篩查。
適應症：Bladder Cancer
收案條件
納入條件
- Age 18 years or above
- Fulfil any one of the following three criteria: (1) Macroscopic haematuria or persistent microscopic haematuria (microscopic haematuria in at least two urine tests), (2) Abnormal urine cytology results (Atypical cells in at least two urine cytology tests, OR Suspicious cells or malignant cells in at least one urine cytology test), (3)History of non-muscle-invasive bladder cancer with complete transurethral resection of bladder tumour performed
排除條件
- Presence of clinically significant cardiovascular disease (History of acute myocardial infarction, presence of uncontrolled angina within 3 months before screening, New York Heart Association Class III or IV congestive heart failure, presence of ventricular arrhythmias, or presence of second-degree or third-degree heart block)
- Any evidence of active urinary tract infection
- Presence of GOLD Stage III or IV chronic obstructive pulmonary disease
- ECOG performance status ≥ 2 (Ambulatory and capable of all self-care but unable to carry our any work activities)
- History of bleeding disorder or use of anti-coagulants
- Presence of other active malignancy
- Pregnancy
收案條件維持 ClinicalTrials.gov 原始英文登錄資料，實際收案資格以研究團隊的正式評估與受試者同意書為準。資料來源：ClinicalTrials.gov，每兩週自動更新，最後同步：2026年10月8日。